Neuroligins provide molecular links between syndromic and nonsyndromic autism

Science Signaling

Volumn 6, Issue 283, 2013, Pages

  Singh, Sandeep K ^a   Eroglu, Cagla ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; NEUROLIGIN;

AUTISM; CENTRAL NERVOUS SYSTEM; ENDOCYTOSIS; HUMAN; MOLECULAR MODEL; NONHUMAN; NONSYNDROMIC AUTISM; PATHOPHYSIOLOGY; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SYNAPSE; SYNAPSE VESICLE; SYNDROMIC AUTISM;

ACTIVATED-LEUKOCYTE CELL ADHESION MOLECULE; ANIMALS; AUTISTIC DISORDER; HUMANS; SYNAPSES; SYNAPTIC TRANSMISSION; SYNDROME;

EID: 84880880241     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2004102     Document Type: Review

References (38)

1. J. H. Miles, Autism spectrum disorders - A genetics review. Genet Med. 13, 278-294 (2011).
2. C. P. Schaaf, H. Y. Zoghbi, Solving the autism puzzle a few pieces at a time. Neuron 70, 806-808 (2011).
3. C.A. Walsh, E. M. Morrow, J. L Rubenstein, Autism and brain development. Cell 135, 396-400 (2008).
4. S. J. Sanders, A. G. Ercan-Sencicek, V. Hus, R. Luo, M. T. Murtha, D. Moreno-De-Luca, S. H. Chu, M. P. Moreau, A. R. Gupta, S. A. Thomson, C. E. Mason, K. Bilguvar, P. B. Celestino-Soper, M. Choi, E. L. Crawford, L Davis, N. R. Wright, R. M. Dhodapkar, M. DiCola, N. M. DiLullo, T. V. Fernandez, V. Fielding-Singh, D. O. Fishman, S. Frahm, R. Garagaloyan, G. S. Goh, S. Kammela, L. Klei, J. K. Lowe, S. C. Lund, A. D. McGrew, K. A. Meyer, W. J. Moffat, J. D. Murdoch, B. J. O'Roak, G. T. Ober, R. S. Pottenger, M. J. Raubeson, Y. Song, Q. Wang, B. L Yaspan, T. W. Yu, I. R. Yurkiewicz, A. L Beaudet, R. M. Cantor, M. Curland, D. E. Grice, M. Günel, R. P. Lifton, S. M. Mane, D. M. Martin, C. A. Shaw, M. Sheldon, J. A. Tischfield, C. A. Walsh, E. M. Morrow, D. H. Ledbetter, E. Fombonne, C. Lord, C. L Martin, A. I. Brooks, J. S. Sutcliffe, E. H. Cook Jr., D. Geschwind, K Roeder, B. Devlin, M. W. State, Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 70, 863-885 (2011).
5. S. J. Sanders, M. T. Murtha, A. R. Gupta, J. D. Murdoch, M. J. Raubeson, A. J. Willsey, A. G. Ercan-Sencicek, N. M. DiLullo, N. N. Parikshak, J. L Stein, M. F. Walker, G. T. Ober, N. A. Teran, Y. Song, P. El-Fishawy, R. C. Murtha, M. Choi, J. D. Overton, R. D. Bjornson, N. J. Carriero, K. A. Meyer, K. Bilguvar, S. M. Mane, N. Sestan, R. P. Lifton, M. Günel, K. Roeder, D. H. Geschwind, B. Devlin, M. W. State, De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 485, 237-241 (2012).
6. S. R. Gilman, I. Iossifov, D. Levy, M. Ronemus, M. Wigler, D. Vitkup, Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron 70, 898-907 (2011).
7. S. Jamain, H. Quach, C. Betancur, M. Råstam, C. Colineaux, I. C. Gillberg, H. Soderstrom, B. Giros, M. Leboyer, C. Gillberg, T. Bourgeron; Paris Autism Research International Sibpair Study, Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 34, 27-29 (2003). (Pubitemid 36548785)
8. T. C. Südhof, Neuroligins and neurexins link synaptic function to cognitive disease. Nature 455, 903-911 (2008).
9. P. Scheiffele, J. Fan, J. Choih, R. Fetter, T. Serafini, Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons. Cell 101, 657-669 (2000).
10. A. M. Craig, Y. Kang, Neurexin-neuroligin signaling in synapse development. Curr. Opin. Neurobiol. 17, 43-52 (2007). (Pubitemid 46227985)
11. S. Baudouin, P. Scheiffele, SnapShot: Neuroligin-neurexin complexes. Cell 141, 908, 908.e1 (2010).
12. B. Chih, H. Engelman, P. Scheiffele, Control of excitatory and inhibitory synapse formation by neuroligins. Science 307, 1324-1328 (2005). (Pubitemid 40299984)
13. F. Varoqueaux, G. Aramuni, R. L. Rawson, R. Mohrmann, M. Missler, K. Gottmann, W. Zhang, T. C. Südhof, N. Brose, Neuroligins determine synapse maturation and function. Neuron 51, 741-754 (2006). (Pubitemid 44374915)
14. A. A. Chubykin, D. Atasoy, M. R. Etherton, N. Brose, E. T. Kavalali, J. R. Gibson, T. C. Südhof, Activity-dependent validation of excitatory versus inhibitory synapses by neuroligin-1 versus neuroligin-2. Neuron 54, 919-931 (2007). (Pubitemid 46907504)
15. H. B. Kwon, Y. Kozorovitskiy, W. J. Oh, R. T. Peixoto, N. Akhtar, J. L. Saulnier, C. Gu, B. L. Sabatini, Neuroligin-1-dependent competition regulates cortical synaptogenesis and synapse number. Nat Neurosci. 15, 1667-1674 (2012).
16. B. Chih, S. K. Afridi, L Clark, P. Scheiffele, Disorder-associated mutations lead to functional inactivation of neuroligins. Hum. Mol. Genet. 13, 1471-1477 (2004). (Pubitemid 39023055)
17. K. Tabuchi, J. Blundell, M. R. Etherton, R. E. Hammer, X. Liu, C. M. Powell, T. C. Südhof, A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 318, 71-76 (2007). (Pubitemid 47538032)
18. M. Etherton, C. Földy, M. Sharma, K. Tabuchi, X. Liu, M. Shamloo, R. C. Malenka, T. C. Südhof, Autism-linked neuroligin-3 R451C mutation differentially alters hippocampal and cortical synaptic function. Proc. Natl. Acad. Sci. U.S.A. 108, 13764-13769 (2011).
19. S. J. Baudouin, J. Gaudias, S. Gerharz, L. Hatstatt, K. Zhou, P. Punnakkal, K. F. Tanaka, W. Spooren, R. Hen, C. I. De Zeeuw, K. Vogt, P. Scheiffele, Shared synaptic pathophysiology in syndromic and nonsyndromic rodent models of autism. Science 338, 128-132 (2012).
20. K. K. Chadman, S. Gong, M. L. Scattoni, S. E. Boltuck, S. U. Gandhy, N. Heintz, J. N. Crawley, Minimal aberrant behavioral phenotypes of neuroligin-3 R451C knockin mice. Autism Res. 1, 147-158 (2008).
21. B. D. Auerbach, E. K. Osterweil, M. F. Bear, Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature 480, 63-68 (2011).
22. +/- mouse model of tuberous sclerosis. Nat. Med. 14, 843-848 (2008).
23. D. D. Krueger, E. K. Osterweil, S. P. Chen, L. D. Tye, M. F. Bear, Cognitive dysfunction and prefrontal synaptic abnormalities in a mouse model of fragile X syndrome. Proc. Natl. Acad. Sci. U.S.A. 108, 2587-2592 (2011).
24. K. M. Huber, S. M. Gallagher, S. T. Warren, M. F. Bear, Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc. Natl. Acad. Sci. U.S.A. 99, 7746-7750 (2002). (Pubitemid 34568762)
25. D. D. Krueger, M. F. Bear, Toward fulfilling the promise of molecular medicine in fragile X syndrome. Annu. Rev. Med. 62, 411-429 (2011).
26. C. Földy, R. C. Malenka, T. C. Südhof, Autism-associated neuroligin-3 mutations commonly disrupt tonic endocannabinoid signaling. Neuron 78, 498-509 (2013).
27. D. D. Krueger, N. Brose, Evidence for a common endocannabinoid-related patho-mechanism in autism spectrum disorders. Neuron 78, 408-410 (2013).
28. M. Maccarrone, S. Rossi, M. Bari, V. De Chiara, C. Rapino, A. Musella, G. Bernardi, C. Bagni, D. Centonze, Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA. Neuropsychopharmacology 35, 1500-1509 (2010).
29. L. Zhang, B. E. Alger, Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome. J. Neurosci. 30, 5724-5729 (2010).
30. K. M. Jung, M. Sepers, C. M. Henstridge, O. Lassalle, D. Neuhofer, H. Martin, M. Ginger, A. Frick, N. V. DiPatrizio, K. Mackie, I. Katona, D. Piomelli, O. J. Manzoni, Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome. Nat. Commun. 3, 1080 (2012).
31. A. Busquets-Garcia, M. Gomis-González, T. Guegan, C. Agustín-Pavón, A. Pastor, S. Mato, A. Pérez-Samartí, C. Matute, R. de la Torre, M. Dierssen, R. Maldonado, A. Ozaita, Targeting the endocannabinoid system in the treatment of fragile X syndrome. Nat. Med. 19, 603-607 (2013).
32. Z. Hu, S. Hom, T. Kudze, X. J. Tong, S. Choi, G. Aramuni, W. Zhang, J. M. Kaplan, Neurexin and neuroligin mediate retrograde synaptic inhibition in C. elegans. Science 337, 980-984 (2012).
33. D. J. Simon, J. M. Madison, A. L. Conery, K. L. Thompson-Peer, M. Soskis, G. B. Ruvkun, J. M. Kaplan, J. K. Kim, The microRNA miR-1 regulates a MEF-2-dependent retrograde signal at neuromuscular junctions. Cell 133, 903-915 (2008). (Pubitemid 351707687)
34. J. H. Foss-Feig, L. D. Kwakye, C. J. Cascio, C. P. Burnette, H. Kadivar, W. L. Stone, M. T. Wallace, An extended multisensory temporal binding window in autism spectrum disorders. Exp. Brain Res. 203, 381-389 (2010).
35. T. P. Roberts, S. Y. Khan, M. Rey, J. F. Monroe, K. Cannon, L. Blaskey, S. Woldoff, S. Qasmieh, M. Gandal, G. L. Schmidt, D. M. Zarnow, S. E. Levy, J. C. Edgar, MEG detection of delayed auditory evoked responses in autism spectrum disorders: Towards an imaging biomarker for autism. Autism Res. 3, 8-18 (2010).
36. M. Zweier, A. Gregor, C. Zweier, H. Engels, H. Sticht, E. Wohlleber, E. K. Bijlsma, S. E. Holder, M. Zenker, E. Rossier, U. Grasshoff, D. S. Johnson, L. Robertson, H. V. Firth, C. Kraus, A. B. Ekici, A. Reis, A. Rauch, Mutations in MEF2C from the 5q14.3q15 microdeletion syndrome region are a frequent cause of severe mental retardation and diminish MECP2 and CDKL5 expression. Hum. Mutat. 31, 722-733 (2010).
37. J. D. Cahoy, B. Emery, A. Kaushal, L. C. Foo, J. L. Zamanian, K. S. Christopherson, Y. Xing, J. L. Lubischer, P. A. Krieg, S. A. Krupenko, W. J. Thompson, B. A. Barres, A transcriptome database for astrocytes, neurons, and oligodendrocytes: A new resource for understanding brain development and function. J. Neurosci. 28, 264-278 (2008).
38. J. Xu, N. Xiao, J. Xia, Thrombospondin 1 accelerates synaptogenesis in hippocampal neurons through neuroligin 1. Nat. Neurosci. 13, 22-24 (2010).